EARGO INC (EAR) Stock Price, Forecast & Analysis
NASDAQ:EAR • US2700872086
EAR Key Statistics, Chart & Performance
The current stock price of EAR is 2.57 USD. In the past month the price decreased by -2.65%. In the past year, price decreased by -66.14%.
EAR Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to EAR. When comparing the yearly performance of all stocks, EAR is a bad performer in the overall market: 90.64% of all stocks are doing better.
EAR Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to EAR. EAR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
EAR Financial Highlights
Over the last trailing twelve months EAR reported a non-GAAP Earnings per Share(EPS) of -57.98. The EPS increased by 90.73% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -154.97% | ||
| ROE | -239.84% | ||
| Debt/Equity | 0 |
EAR Forecast & Estimates
8 analysts have analysed EAR and the average price target is 2.04 USD. This implies a price decrease of -20.62% is expected in the next year compared to the current price of 2.57.
For the next year, analysts expect an EPS growth of 93.38% and a revenue growth 19.87% for EAR
EAR Ownership
EAR Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.95 | 199.24B | ||
| ISRG | INTUITIVE SURGICAL INC | 48.33 | 175.441B | ||
| SYK | STRYKER CORP | 25.22 | 145.828B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.46 | 111.449B | ||
| BDX | BECTON DICKINSON AND CO | 11.58 | 51.993B | ||
| IDXX | IDEXX LABORATORIES INC | 43.82 | 51.841B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.72 | 47.817B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.73 | 38.306B | ||
| RMD | RESMED INC | 20.49 | 36.658B | ||
| DXCM | DEXCOM INC | 28.95 | 28.507B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About EAR
Company Profile
Eargo, Inc. is engaged in the development of hearing aids and headsets solutions. The company is headquartered in San Jose, California and currently employs 243 full-time employees. The company went IPO on 2020-10-16. The firm is engaged in developing products to improve the quality of life of people with hearing loss. Its Eargo hearing aids are virtually invisible, rechargeable, completely in-the-canal devices indicated to compensate for mild to moderate hearing loss. Its in-the-canal devices feature quality audio, which are designed to provide up to 16 hours of battery life and feature its soft flexible medical-grade silicon tips. The company is marketing various versions of hearing aids, the Eargo Max, the Eargo Neo HiFi, Eargo 5, Eargo 6 and Eargo 7. The firm markets and sells its hearing aids primarily in a direct-to-consumer format, engaging consumers through a mix of digital and traditional marketing as well as select commercial partnership, and omni-channel (including retail). Its devices are self-fitting hearing aids and are adjusted by the user to meet the user’s hearing needs, without pre-programming or a hearing test from a hearing care professional.
Company Info
EARGO INC
2665 North First Street, Suite 300
San Jose CALIFORNIA 95110 US
CEO: Christian Gormsen
Employees: 243
Phone: 16503517700
EARGO INC / EAR FAQ
What does EARGO INC do?
Eargo, Inc. is engaged in the development of hearing aids and headsets solutions. The company is headquartered in San Jose, California and currently employs 243 full-time employees. The company went IPO on 2020-10-16. The firm is engaged in developing products to improve the quality of life of people with hearing loss. Its Eargo hearing aids are virtually invisible, rechargeable, completely in-the-canal devices indicated to compensate for mild to moderate hearing loss. Its in-the-canal devices feature quality audio, which are designed to provide up to 16 hours of battery life and feature its soft flexible medical-grade silicon tips. The company is marketing various versions of hearing aids, the Eargo Max, the Eargo Neo HiFi, Eargo 5, Eargo 6 and Eargo 7. The firm markets and sells its hearing aids primarily in a direct-to-consumer format, engaging consumers through a mix of digital and traditional marketing as well as select commercial partnership, and omni-channel (including retail). Its devices are self-fitting hearing aids and are adjusted by the user to meet the user’s hearing needs, without pre-programming or a hearing test from a hearing care professional.
What is the current price of EAR stock?
The current stock price of EAR is 2.57 USD. The price decreased by -4.1% in the last trading session.
Does EAR stock pay dividends?
EAR does not pay a dividend.
What is the ChartMill technical and fundamental rating of EAR stock?
EAR has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the GICS sector and industry of EAR stock?
EARGO INC (EAR) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Is EARGO INC (EAR) expected to grow?
The Revenue of EARGO INC (EAR) is expected to grow by 19.87% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
How many employees does EARGO INC have?
EARGO INC (EAR) currently has 243 employees.